Pharmacology of vitamin D: Anything new?

Osteologie

Volumn 20, Issue 4, 2011, Pages 299-303

  Glossmann, Hartmut H ^a  

^a UNIVERSITY OF INNSBRUCK   (Austria)

Author keywords

Apolipoprotein E; Calcidiol plasma levels; Intestinal transport; Vitamin D

Indexed keywords

APOLIPOPROTEIN E; CALCIDIOL; CHOLESTEROL; COLECALCIFEROL; DELTA 7 DEHYDROCHOLESTEROL REDUCTASE; DRUG RECEPTOR; EZETIMIBE; LONG CHAIN FATTY ACID; OXIDOREDUCTASE; UNCLASSIFIED DRUG; VITAMIN D;

BIOAVAILABILITY; CARDIOVASCULAR DISEASE; CELL CULTURE; DIET; EUROPE; EVOLUTIONARY ADAPTATION; FINLAND; GENE FREQUENCY; GENE MUTATION; GENOTYPE; HUMAN; INTESTINE ABSORPTION; INTESTINE CELL; MEAT; MEDITERRANEAN SEA; MORTALITY; NONHUMAN; REVIEW; SERUM; SKIN; SMALL INTESTINE; SUN EXPOSURE; VITAMIN BLOOD LEVEL; VITAMIN D METABOLISM; VITAMIN INTAKE; WINTER;

EID: 84856070407     PISSN: 10191291     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0037-1620006     Document Type: Review

References (33)

1. Mawer EB, Backhouse J, Holman CA et al. The distribution and storage of vitamin D and its metabolites in human tissues. Clin Sci 1972; 43 (3): 413-431.
2. 3 in primary biliary cirrhosis. Lancet 1977; 2 (8051): 1246-1249.
3. 3H in control subjects and patients with intestinal malabsorption. J Clin Invest 1966; 45 (1): 94-102.
4. 3 from two different lipid vehicles in man: comparison of peanut oil and a medium chain triglyceride. Biopharm Drug Dispos 1990; 11 (9): 807-815.
5. 3 Combination Tablet. The Journal of Clinical Pharmacology 2010; doi: 10.1177/0091270010382010
6. Bosner MS, Lange LG, Stenson WF, Ostlund RE. Percent cholesterol absorption in normal women and men quantified with dual stable isotopic tracers and negative ion mass spectrometry. J Lipid Res 1999; 40 (2): 302-308. (Pubitemid 29069805)
7. Masson CJ, Plat J, Mensink RP et al. Fatty acid- and cholesterol transporter protein expression along the human intestinal tract. PLoS ONE 2010; 5 (4): e10380.
8. Binkley N, Gemar D, Engelke J et al. Evaluation of ergocalciferol or cholecalciferol dosing, 1,600 IU daily or 50,000 IU monthly in older adults. J Clin Endocrinol Metab 2011; 96 (4): 981-988.
9. Russo S, Carlucci L, Cipriani C et al. Metabolic Changes Following 500 μg Monthly Administration of Calcidiol: A Study in Normal Females. Calcif Tissue Int 2011; 89 (3): 252-257.
10. Barger-Lux MJ, Heaney RP, Dowell S et al. Vitamin D and its major metabolites: serum levels after graded oral dosing in healthy men. Osteoporos Int 1998; 8 (3): 222-230. (Pubitemid 28427071)
11. Vieth R. Presystemic 24-hydroxylation of oral 25-hydroxyvitamin D3 in rats. J. Bone Miner Res 1990; 5 (11): 1177-1182. (Pubitemid 20373526)
12. Menegaz D, Mizwicki MT, Barrientos-Duran A et al. Vitamin D Receptor (VDR) Regulation of Voltage-Gated Chloride Channels by Ligands Preferring a VDR-Alternative Pocket (VDR-AP). Molecular endocrinology (Baltimore, Md.) 2011 June 09.
13. Lou Y, Molnár F, Peräkylä M et al. 25-Hydroxyvitamin D(3) is an agonistic vitamin D receptor ligand. J Steroid Biochem Mol Biol 2010; 118 (3): 162-170.
14. Glossmann HH. Are all steaks created equal? Public Health Nutr 2011; 14 (6): 1128.
15. Chun R, Gacad MA, Hewison M, Adams JS. Adenosine 5′-triphosphate- dependent vitamin D sterol binding to heat shock protein-70 chaperones. Endocrinology 2005; 146 (12): 5540-5544. (Pubitemid 41653069)
16. 3in raw and cooked New Zealand beef and lamb. Journal of Food Composition and Analysis 2007; 20(2): 90-98.
17. Jia L, Betters JL, Yu L. Niemann-pick C1-like 1 (NPC1L1) protein in intestinal and hepatic cholesterol transport. Annu Rev Physiol 2011; 73: 239-259.
18. Reboul E, Goncalves A, Comera C et al. Vitamin D intestinal absorption is not a simple passive diffusion: evidences for involvement of cholesterol transporters. Mol Nutr Food Res 2011; 55 (5): 691-702.
19. Goncalves A, Gleize B, Bott R et al. Phytosterols can impair vitamin D intestinal absorption in vitro and in mice. Mol Nutr Food Res 2011; doi:10.1002/mnfr.201100055
20. Weinglass AB, Köhler MG, Nketiah EO et al. Madin-Darby canine kidney II cells: a pharmacologically validated system for NPC1L1-mediated cholesterol uptake. Mol Pharmacol 2008; 73 (4): 1072-1084. (Pubitemid 351439189)
21. Kwon HJ, Palnitkar M, Deisenhofer J. The structure of the NPC1L1 N-terminal domain in a closed conformation. PLoS ONE 2011; 6 (4): e18722.
22. Zhang J, Ge L, Qi W et al. The N-terminal Domain of NPC1L1 Protein Binds Cholesterol and Plays Essential Roles in Cholesterol Uptake. J Biol Chem 2011; 286 (28): 25088-25097.
23. Turley SD. The role of Niemann-Pick C1-Like 1 (NPC1L1) in intestinal sterol absorption. Journal of clinical lipidology 2008; 2 (2): S20-S28. (Pubitemid 351372950)
24. Gylling H, Miettinen TA. Inheritance of cholesterol metabolism of probands with high or low cholesterol absorption. J. Lipid Res 2002; 43 (9): 1472-1476.
25. Nunes VS, Leança CC, Panzoldo NB et al. HDL-C concentration is related to markers of absorption and of cholesterol synthesis: Study in subjects with low vs. high HDL-C. Clin Chim Acta 2011; 412 (1-2): 176-180.
26. Jorde R, Grimnes G. Vitamin D and metabolic health with special reference to the effect of vitamin D on serum lipids. Progress in lipid research 2011; 50 (4): 303-312.
27. Wang TJ, Zhang F, Richards JB et al. Common genetic determinants of vitamin D insufficiency: a genome- wide association study. Lancet 2010; 376 (9736): 180-188.
28. Porter FD, Herman GE. Malformation syndromes caused by disorders of cholesterol synthesis. The Journal of Lipid Research 2010; 52 (1): 6-34.
29. Gerdes LU. The common polymorphism of apolipoprotein E: geographical aspects and new pathophysiological relations. Clin Chem Lab Med 2003; 41 (5): 628-631.
30. Eisenberg DTA, Kuzawa CW, Hayes MG. Worldwide allele frequencies of the human apolipoprotein E gene: climate, local adaptations, and evolutionary history. Am J Phys Anthropol 2010; 143 (1): 100-111.
31. Huebbe P, Nebel A, Siegert S et al. APOE {varepsilon} 4 is associated with higher vitamin D levels in targeted replacement mice and humans. FASEB J 2011; 25 (9): 3262-3270. Epub 2011 Jun 9.
32. 3 secretion. PLoS Biol 2006; 4 (8): e232.
33. Bischoff-Ferarri HA, Dawson-Hughes B, Stöcklin E et al. Oral supplementation with 25(OH)D(3) versus vitamin D(3): effects of 25(OH)D levels, lower extremity function, blood pressure and markers of innate immunity. J Bone Miner Res 2011 Oct 25. doi: 10.1002/jbmr.551.